|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.34 USD | +0.87% |
|
-3.79% | -0.56% |
| 07-31 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 07-28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 1,984 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 0.86% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 1,831 | 1,757 | 1,662 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | -2.24% | -4.05% | -5.41% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 369x | 93.1x | 56.1x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 3.44x | 3.06x | 2.67x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -3x | 0x | 0.9x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 3.27x | 2.92x | 2.59x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 3.02x | 2.58x | 2.17x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 21x | 17.3x | 13.4x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 160x | 70.3x | 39.1x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 34.5x | 43.9x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.9% | 2.28% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4188 | 0.6947 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.6 | 764.6 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.37 | 101.6 | 123.9 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.51 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.12 | 20.79 | 35.23 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -153 | -227.2 | -322.2 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 39.00 | 39.00 | 39.00 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 369.39x | 3.02x | 20.95x | - | 1.98B | |
| 30.2x | 4.11x | 15.95x | 2.44% | 182B | |
| 19.53x | 3.41x | 11.99x | 3.45% | 110B | |
| 17.04x | 0.19x | 12.04x | 0.77% | 59.59B | |
| 31.84x | 7.93x | 20.18x | 1.25% | 55.04B | |
| 37.04x | 3.28x | 11.19x | 2.31% | 46.87B | |
| 40.3x | 1.45x | 12.76x | 0.2% | 35.55B | |
| 35.05x | 6.15x | 19.32x | -.--% | 32.81B | |
| 40.67x | 7.12x | 25.57x | 0.26% | 24.54B | |
| 25.64x | 3.76x | 13.17x | 1.12% | 22.69B | |
| Average | 64.67x | 4.04x | 16.31x | 1.31% | 57.19B | |
| Weighted average by Cap. | 29.84x | 3.93x | 15.11x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
